Jolley Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-9,568
| Closed | -$318K | – | 183 |
|
|
2017
Q2 | $318K | Sell |
9,568
-13,950
| -59% | -$464K | 0.22% | 55 |
|
|
2017
Q1 | $755K | Buy |
23,518
+13,640
| +138% | +$438K | 0.54% | 38 |
|
|
2016
Q4 | $358K | Sell |
9,878
-100
| -1% | -$3.62K | 0.26% | 48 |
|
|
2016
Q3 | $459K | Buy |
9,978
+500
| +5% | +$23K | 0.37% | 40 |
|
|
2016
Q2 | $476K | Buy |
9,478
+1,550
| +20% | +$77.8K | 0.38% | 42 |
|
|
2016
Q1 | $424K | Buy |
7,928
+900
| +13% | +$48.1K | 0.39% | 39 |
|
|
2015
Q4 | $461K | Sell |
7,028
-802
| -10% | -$52.6K | 0.44% | 41 |
|
|
2015
Q3 | $442K | Hold |
7,830
| – | – | 0.45% | 40 |
|
|
2015
Q2 | $463K | Sell |
7,830
-40
| -0.5% | -$2.37K | 0.42% | 42 |
|
|
2015
Q1 | $490K | Sell |
7,870
-100
| -1% | -$6.23K | 0.41% | 44 |
|
|
2014
Q4 | $458K | Sell |
7,970
-535
| -6% | -$30.7K | 0.38% | 45 |
|
|
2014
Q3 | $457K | Sell |
8,505
-30
| -0.4% | -$1.61K | 0.37% | 45 |
|
|
2014
Q2 | $447K | Sell |
8,535
-6,820
| -44% | -$357K | 0.33% | 53 |
|
|
2014
Q1 | $811K | Buy |
15,355
+10,000
| +187% | +$528K | 0.6% | 40 |
|
|
2013
Q4 | $215K | Sell |
5,355
-9,000
| -63% | -$361K | 0.17% | 54 |
|
|
2013
Q3 | $542K | Sell |
14,355
-11,850
| -45% | -$447K | 0.45% | 45 |
|
|
2013
Q2 | $1.03M | Buy |
+26,205
| New | +$1.03M | 0.83% | 34 |
|